Advisory Board Members
In the spring of 2015, AVT realigned its executive management team. Dr. Abraham Mittelman assumed duties as the President in addition to Chairman of the Board and CEO. Mr. Robert Gardner of New World Technology Partners joined the Board of Directors. And AVT changed its entire support team of Legal Counsel, Accountants, Investor Relations, and others.
Joseph Bertino, MD,
Associate Director and Chief Scientific Officer, The Cancer Institute of New Jersey and past President of the American Association for Cancer Research and The American Association of Clinical Oncologists; founding Editor of the Journal of Clinical Oncology.
Charles Cantor, PhD,
Director of the Center for Advanced Biotechnology at Boston University and Chief Scientific Officer at Sequenom, Inc. Author of “Genomics: The Science and Technology Behind the Human Genome Project”.
Roy G. Smith, PhD,
Director of Huffington Center on Aging, Professor in the Department of Molecular and Cellular Biology, and Professor in the Department of Medicine at Baylor College of Medicine. Past Vice President of Basic Research at Merck .
Pramod Srivastava, PhD,
Professor of immunology at the University of Connecticut Endowed Chair in Cancer Immunology; Director of the Cancer Center and the Scientific Founder of Antigenics.